These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15170189)

  • 1. Collaboration may be the cure for what ails drug development.
    Erickson AK
    Nat Med; 2004 Jun; 10(6):558. PubMed ID: 15170189
    [No Abstract]   [Full Text] [Related]  

  • 2. Arguments against precompetitive collaboration.
    Vargas G; Boutouyrie B; Ostrowitzki S; Santarelli L
    Clin Pharmacol Ther; 2010 May; 87(5):527-9. PubMed ID: 20407456
    [No Abstract]   [Full Text] [Related]  

  • 3. Open-minded to open innovation and precompetitive collaboration.
    Wagner JA
    Clin Pharmacol Ther; 2010 May; 87(5):511-5. PubMed ID: 20407451
    [No Abstract]   [Full Text] [Related]  

  • 4. The cystic fibrosis drug market.
    Syed BA; Hamad B
    Nat Rev Drug Discov; 2014 Oct; 13(10):721-2. PubMed ID: 25270952
    [No Abstract]   [Full Text] [Related]  

  • 5. The Biomarkers Consortium: practice and pitfalls of open-source precompetitive collaboration.
    Wagner JA; Prince M; Wright EC; Ennis MM; Kochan J; Nunez DJ; Schneider B; Wang MD; Chen Y; Ghosh S; Musser BJ; Vassileva MT
    Clin Pharmacol Ther; 2010 May; 87(5):539-42. PubMed ID: 20407460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nurturing European collaboration.
    Nat Rev Drug Discov; 2008 Jul; 7(7):548-9. PubMed ID: 18591973
    [No Abstract]   [Full Text] [Related]  

  • 7. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
    Avanzini G; Engel J
    Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
    [No Abstract]   [Full Text] [Related]  

  • 8. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deal watch: Ablynx and Merck Serono collaborate on next-generation antibody products.
    Nat Rev Drug Discov; 2008 Nov; 7(11):881. PubMed ID: 18974745
    [No Abstract]   [Full Text] [Related]  

  • 10. Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    Ramsey BW; Nepom GT; Lonial S
    N Engl J Med; 2017 May; 376(18):1762-1769. PubMed ID: 28467868
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug discovery through industry-academic partnerships.
    Gray NS
    Nat Chem Biol; 2006 Dec; 2(12):649-53. PubMed ID: 17108976
    [No Abstract]   [Full Text] [Related]  

  • 12. A pipeline of therapies for cystic fibrosis.
    Ashlock MA; Beall RJ; Hamblett NM; Konstan MW; Penland CM; Ramsey BW; Van Dalfsen JM; Wetmore DR; Campbell PW
    Semin Respir Crit Care Med; 2009 Oct; 30(5):611-26. PubMed ID: 19760548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outlook: finding improved medicines: the role of academic-industrial collaboration.
    Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
    Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
    Kamel N; Compton C; Middelveld R; Higenbottam T; Dahlén SE
    Eur Respir J; 2008 May; 31(5):924-6. PubMed ID: 18448501
    [No Abstract]   [Full Text] [Related]  

  • 15. Bridging the drug-diagnostic divide.
    Opar A
    Nat Rev Drug Discov; 2011 May; 10(5):323-4. PubMed ID: 21532548
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer drug discovery through collaboration.
    Lengauer C; Diaz LA; Saha S
    Nat Rev Drug Discov; 2005 May; 4(5):375-80. PubMed ID: 15864266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to drug development.
    Brown S
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099948
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic alliance management: lessons learned from the Bayer-Millennium collaboration.
    Ziegelbauer K; Farquhar R
    Drug Discov Today; 2004 Oct; 9(20):864-8. PubMed ID: 15475317
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.